TABLE 2.
Carnitines of the FES patients at baseline and after 4 weeks.
| Carnitine, median (IQR) | First-episode (104) | After 4 weeks (104) | Z(p) |
|---|---|---|---|
| Linoelaidyl carnitine | 9.2 (3.1, 327.4) | 54.0 (39.2, 71.8) | −0.3 (0.82) |
| 2-Octenoylcarnitine | 164.9 (83.5, 321.5) | 4.9 (2.7, 10.9) | −3.8 (<0.001) |
| Butyrylcarnitine | 94.9 (58.7, 230.5) | 125.3 (69.6, 224.5) | −1.3 (0.20) |
| 11Z-Octadecenylcarnitine | 14.9 (2.3, 189.1) | 203.4 (129.2, 317.3) | −2.2 (0.03) |
| 9-Decenoylcarnitine | 3.2 (2.2, 4.5) | 14.5 (1.8, 194.8) | −2.9 (0.004) |
| Propionylcarnitine | 38.5 (14.0, 72.8) | 30.0 (13.2, 55.1) | −1.4 (0.17) |
| L-Palmitoylcarnitine | 89.0 (35.4, 279.3) | 3.5 (2.8, 4.0) | −4.4 (<0.001) |